Repository logo
Communities
Research Outputs
Projects
Researchers
Statistics
  • Feedback
New user? Click here to register.Have you forgotten your password?
  1. Home
  2. CRIS
  3. Publications
  4. In Silico Identification of Potential Clovibactin-like Antibiotics Binding to Unique Cell Wall Precursors in Diverse Gram-Positive Bacterial Strains
Details

In Silico Identification of Potential Clovibactin-like Antibiotics Binding to Unique Cell Wall Precursors in Diverse Gram-Positive Bacterial Strains

Journal
International Journal of Molecular Sciences
ISSN
1422-0067
Publisher
MDPI
Date Issued
2025-02-18
Author(s)
Sierra-Hernandez, Olimpo
Saurith-Coronell, Oscar
Rodríguez-Macías, Juan
Márquez, Edgar
Ramón Mora, José
Paz, José L.
Flores-Sumoza, Maryury
Mendoza-Mendoza, Adel
Flores-Morales, Virginia
Barigye, Stephen J.
Type
text::journal::journal article
DOI
10.3390/ijms26041724
URL
https://scripta.up.edu.mx/handle/20.500.12552/12050
Abstract
The rise in multidrug-resistant bacteria highlights the critical need for novel antibiotics. This study explores clovibactin-like compounds as potential therapeutic agents targeting lipid II, a crucial component in bacterial cell wall synthesis, using in silico techniques. A total of 2624 clovibactin analogs were sourced from the PubChem database and screened using ProTox 3.0 software based on their ADME-Tox properties, prioritizing candidates with favorable pharmacokinetic profiles and minimal toxicity. Molecular docking protocols were then employed to assess the binding interactions of the selected compounds with lipid II. Our analysis identified Compound 22 as a particularly promising candidate, exhibiting strong binding affinity, stable complex formation, and high selectivity for the target. Binding energy analysis, conducted via molecular dynamics simulations, revealed a highly negative value of −25.50 kcal/mol for Compound 22, surpassing that of clovibactin and underscoring its potential efficacy. In addition, Compound 22 was prioritized due to its exceptional binding affinity to lipid II and its favorable ADME-Tox properties, suggesting a lower likelihood of adverse effects. These characteristics position Compound 22 as a promising candidate for further pharmacological development. While our computational results are encouraging, experimental validation is essential to confirm the efficacy and safety of these compounds. This study not only advances our understanding of clovibactin analogs but also contributes to the ongoing efforts to combat antimicrobial resistance through innovative antibiotic development. ©The authors ©International Journal of Molecular Sciences ©MDPI.
Subjects

Clovibactin analogs

In silico

Lipid II

Molecular dynamics

ADME-Tox

Cell wall synthesis

Solvation energy

Ligand-receptor inter...

Binding affinity prop...

License
Acceso Abierto
URL License
https://creativecommons.org/licenses/by-nc-sa/4.0/
How to cite
Sierra-Hernandez, O., Saurith-Coronell, O., Rodríguez-Macías, J., Márquez, E., Mora, J. R., Paz, J. L., Flores-Sumoza, M., Mendoza-Mendoza, A., Flores-Morales, V., Marrero-Ponce, Y., Barigye, S. J., & Martinez-Rios, F. (2025). In Silico Identification of Potential Clovibactin-like Antibiotics Binding to Unique Cell Wall Precursors in Diverse Gram-Positive Bacterial Strains. International Journal of Molecular Sciences, 26(4), 1724. https://doi.org/10.3390/ijms26041724
Table of contents
Abstract -- Introduction -- Results and Discussion -- Materials and Methods -- Conclusions -- Author Contributions -- Funding -- Institutional Review Board Statement -- Informed Consent Statement -- Data Availability Statement -- Acknowledgments -- Conflicts of Interest -- References.

Hosting & Support by

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Accessibility settings
  • Privacy policy
  • End User Agreement
  • Send Feedback
Repository logo COAR Notify